Lanean...
Progress in endocrine approaches to the treatment and prevention of breast cancer
Tamoxifen had been the only available hormonal option for the systemic treatment for breast cancer from 1979–2000. Enormous efforts have led to the development of potent and selective third generation aromatase inhibitors including anastrozole, letrozole and exemestane. Due to their superior efficac...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3518840/ https://ncbi.nlm.nih.gov/pubmed/21982237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.maturitas.2011.09.006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|